Received Mar 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | 1965046 | OT |
No adverse side effects were reported.; Inbound call from HCP reporting GARDASIL 9 that was out of range, unmonitored for an unknown amount of time at unknown temperatures. Lot number was provided, expiration date was unknown. Administered 2/6/2025. Consent to contact is yes. No adverse si; This spontaneous report was received from Other health professional and refers to a 24-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 06-Feb-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, dose, frequency, route of administration, vaccination site, and vaccination scheme were not provided; lot # 1965046, which has been verified as a valid number, and expiration date reported and validated as 22-Jan-2026) as a prophylaxis. The vaccine was out of range, unmonitored for an unknown amount of time at unknown temperatures (improper storage of product in use). However, no adverse side effects were reported.